| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC11811 | SCY-078 | A novel orally bioavailable fungal beta-1,3-D glucan synthetase inhibitor against Candida species C. glabrata (MIC 0.03 to 0.25 ug/ml), C. parapsilosis (MIC 0.06 to 0.25 ug/ml). |
|
| DCAPI1497 | Cancidas Featured | Caspofungin is a semi-synthetic analogue of pneumocandin B0 with improved water solubility, a significant limitation in the development of the echinocandin class as pharmaceuticals. Caspofungin acts by inhibition of the synthesis of β (1,3)-D-glucan, an e |
|
| DC7824 | Fosfluconazole(INN) | Fosfluconazole (INN) is a water-soluble phosphate prodrug of fluconazole |
|
| DCAPI1366 | Itraconazole (Sporanox) | Itraconazole (Sporanox) |
|
| DCAPI1093 | Posaconazole Featured | Posaconazole (Noxafil) is a sterol C14ɑ demethylase inhibitor with an IC50 of 0.25 nM. |
|
| DCAPI1383 | Terbinafine (Lamisil, Terbinex) | Terbinafine (Lamisil, Terbinex) |
|
| DCAPI1344 | Terbinafine HCl Featured | Terbinafine also known under the trade name Lamisil. It is highly hydrophobic and tends to accumulate in hair, skin, nails, and fatty tissue. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system. |
|
| DCAPI1451 | Voriconazole Featured | Voriconazole is an ergosterol biosynthesis inhibitor, as well as systemic antifungal. This compound, like many antifungal agents, is an inhibitor of CYP2C9, an enzyme involved in the oxidative metabolism of many xenobiotics. |
|
